Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

28.11
+0.03740.13%
Volume:278
Turnover:8K
Market Cap:1.41M
PE:- -
High:28.11
Open:28.07
Low:28.11
Close:28.07
52wk High:29.89
52wk Low:24.32
Shares:50.00K
Float Shares:50.00K
Volume Ratio:1.70
T/O Rate:0.56%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

LIVE Markets-Big Beauty Faces Growing Threat from AI, Smaller Rivals

Reuters
·
Sep 21

ADARx Pharmaceuticals to Sell 21.9 Million Shares at $15-$17 Each in IPO

Dow Jones
·
Sep 21

Drug Developer ADARx Seeks $1.74 Billion Valuation in US IPO

Reuters
·
Sep 21

Align Technology Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 19

AbbVie presents new Vraylar data at Psych Congress 2026

TIPRANKS
·
Sep 18

AbbVie Says Real-World Studies Show Vraylar Improves Symptoms in MDD, Bipolar I Depression

Reuters
·
Sep 18

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 18

Hims & Hers CTO Mohamed Elshenawy Sells 7,954 Shares Worth $225,421.06

Reuters
·
Sep 18

AbbVie Targets Dry Eye Market Upside With New ABBV-444 Trial Update

TIPRANKS
·
Sep 18

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

Reuters
·
Sep 18

Niagen Bioscience Names Martin Hendrix Strategic Adviser for Corporate Strategy, M&A

Reuters
·
Sep 17

AbbVie’s Allergan Aesthetics presents clinical data on skin quality improvement

TIPRANKS
·
Sep 17

Align Technology Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 17

Estée Lauder Declares Q3 2026 Dividend of R$ 0.05 Per Unit

Reuters
·
Sep 17

Moderately bullish activity in Hims and Hers Health with shares up 0.47%

TIPRANKS
·
Sep 17

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 16

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 16

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
Sep 15